Published by Coherent Market Insights
Posted on September 22, 2021
Gumboro Disease Market Report 2021-2027 includes a comprehensive analysis of the present Market. The report starts with the basic Gumboro Disease industry overview and then goes into each and every detail.
Gumboro Disease Market Report contains in depth information major manufacturers, opportunities, challenges, and industry trends and their impact on the market forecast. Gumboro Disease also provides data about the company and its operations. This report also provides information on the Pricing Strategy, Brand Strategy, Target Client, Distributors/Traders List offered by the company.
Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/783
Infectious bursal disease, commonly known as gumboro disease, is a viral infection caused by infectious bursal disease virus. Symptoms of the condition include, depression, watery diarrhea, ruffled feathers, and dehydration. There is no effective treatment for the infection. Gumboro disease may lead to heavy losses to industrial poultry and is classified as one of the main diseases in almost all countries of the world.
Key Market Drivers:
Increasing consumption of chicken is expected to propel growth of the global gumboro disease market over the forecast period. For instance, according to the U.S. Department of Agriculture/Economic Research Service analysis, per capita consumption of broilers in 2020 is projected to be 1.6% higher than 2019. The growth will continue in 2021, with projected consumption growing by 0.7% to 44.1kgs.
Moreover, circulation of new variants of disease is also expected to aid in growth of the global gumboro disease market over the forecast period. Several studies have reported the circulation of new vvIBDV strains since late 2018 in the United Kingdom, the Netherlands, Belgium and France.
Key Market Restraints:
Decline in production of chicken is expected to hinder growth of the gumboro disease market. For instance, according to a report published by the United States Department of Agriculture in April 2021, the U.S. recorded US$ 21.7 billion in production of broilers during 2020, which was a 23% decline compared to 2019.
Covid-19 Impact Analysis
In United States of America, from 3 January 2020 to 6:28pm CEST, 17 August 2021, there have been 36,547,639 confirmed cases of COVID-19 with 616,711 deaths, reported to WHO. As various government focus on developing and enhancing the current biosecurity measurements in the poultry sector, the demand for vaccines against various infections in chickens is expected to increase. This in turn is expected to offer lucrative growth opportunities for players in the gumboro disease market.
Key Takeaways
The gumboro disease market is expected to exhibit a CAGR of XX % over the forecast period, owing to adoption of new poultry welfare standards. For instance, in August 2021, supermarkets in the Netherlands announced to sell only fresh chicken with at least one “Beter Leven” star by the end of 2023.
Among regions, Europe is expected to witness decline in the gumboro disease market with various challenges in the poultry sector due to Brexit. For instance, in August 2021, British Poultry Council reported the British poultry meat industry is facing a significant shortage of workers across farming and processing majorly due to the effects of Brexit.
Top Key Players Include In Gumboro Disease Market: Ceva, ROMVAC Company SA, PTSanbe Farma, Jiangyin Caina Technology co. limited, Cios Co., Salfarm Danmark A/s., Vetbiochem, and others.
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/783
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post New Empirical Research Report on Gumboro Disease Market by Forecast to 2021 to 2027 with Covid-19 Impact Analysis and Future Business Opportunities appeared first on Gatorledger.
Gumboro Disease Market Report 2021-2027 includes a comprehensive analysis of the present Market. The report starts with the basic Gumboro Disease industry overview and then goes into each and every detail.
Gumboro Disease Market Report contains in depth information major manufacturers, opportunities, challenges, and industry trends and their impact on the market forecast. Gumboro Disease also provides data about the company and its operations. This report also provides information on the Pricing Strategy, Brand Strategy, Target Client, Distributors/Traders List offered by the company.
Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/783
Infectious bursal disease, commonly known as gumboro disease, is a viral infection caused by infectious bursal disease virus. Symptoms of the condition include, depression, watery diarrhea, ruffled feathers, and dehydration. There is no effective treatment for the infection. Gumboro disease may lead to heavy losses to industrial poultry and is classified as one of the main diseases in almost all countries of the world.
Key Market Drivers:
Increasing consumption of chicken is expected to propel growth of the global gumboro disease market over the forecast period. For instance, according to the U.S. Department of Agriculture/Economic Research Service analysis, per capita consumption of broilers in 2020 is projected to be 1.6% higher than 2019. The growth will continue in 2021, with projected consumption growing by 0.7% to 44.1kgs.
Moreover, circulation of new variants of disease is also expected to aid in growth of the global gumboro disease market over the forecast period. Several studies have reported the circulation of new vvIBDV strains since late 2018 in the United Kingdom, the Netherlands, Belgium and France.
Key Market Restraints:
Decline in production of chicken is expected to hinder growth of the gumboro disease market. For instance, according to a report published by the United States Department of Agriculture in April 2021, the U.S. recorded US$ 21.7 billion in production of broilers during 2020, which was a 23% decline compared to 2019.
Covid-19 Impact Analysis
In United States of America, from 3 January 2020 to 6:28pm CEST, 17 August 2021, there have been 36,547,639 confirmed cases of COVID-19 with 616,711 deaths, reported to WHO. As various government focus on developing and enhancing the current biosecurity measurements in the poultry sector, the demand for vaccines against various infections in chickens is expected to increase. This in turn is expected to offer lucrative growth opportunities for players in the gumboro disease market.
Key Takeaways
The gumboro disease market is expected to exhibit a CAGR of XX % over the forecast period, owing to adoption of new poultry welfare standards. For instance, in August 2021, supermarkets in the Netherlands announced to sell only fresh chicken with at least one “Beter Leven” star by the end of 2023.
Among regions, Europe is expected to witness decline in the gumboro disease market with various challenges in the poultry sector due to Brexit. For instance, in August 2021, British Poultry Council reported the British poultry meat industry is facing a significant shortage of workers across farming and processing majorly due to the effects of Brexit.
Top Key Players Include In Gumboro Disease Market: Ceva, ROMVAC Company SA, PTSanbe Farma, Jiangyin Caina Technology co. limited, Cios Co., Salfarm Danmark A/s., Vetbiochem, and others.
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/783
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post New Empirical Research Report on Gumboro Disease Market by Forecast to 2021 to 2027 with Covid-19 Impact Analysis and Future Business Opportunities appeared first on Gatorledger.
Explore more articles in the Research Reports category
